4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury.

EMBO Mol Med · 2016 · PMC5167128 · PMID 27861125

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

Small, but not yet significant, increases in NCV were seen as early as 7 days after initiation of 4‐AP treatment.

also in 316 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.